Abstract 15070: Prognostic Value of Cardiac Magnetic Resonance Myocardial Strain in Cardiac Amyloidosis with Preserved Ejection Fraction
Abstract
Introduction: Cardiac amyloidosis causes progressive myocardial infiltration and carries a poor prognosis, yet risk stratification when ejection fraction is preserved remains difficult. Because left ventricular ejection fraction (LVEF) is often preserved until advanced disease and may underestimate myocardial dysfunction, strain imaging may improve risk stratification. Research Question: We evaluated whether cardiac magnetic resonance (CMR)-derived myocardial strain is independently associated with all-cause mortality among patients with cardiac amyloidosis and preserved LVEF. Methods: We performed a single-center retrospective cohort study at a tertiary hospital using a CMR database spanning 2008-2023. Eligible patients met established diagnostic criteria for cardiac amyloidosis, including histologic confirmation by endomyocardial biopsy, extracardiac biopsy with characteristic CMR findings of cardiac involvement, or grade 2-3 technetium-99m pyrophosphate uptake in the absence of monoclonal gammopathy. Amyloid subtypes were classified as light-chain amyloidosis (AL) or transthyretin amyloidosis (TTR) based on histopathology and nuclear imaging. Studies with poor image quality were excluded. Left ventricular (LV) and right ventricular (RV) global longitudinal strain were quantified with feature-tracking dedicated software. The primary outcome was all-cause mortality from the date of CMR. The primary predictors were LVEF and CMR-derived LV and RV longitudinal strain. Cox proportional hazards models adjusted for age, sex, and amyloid subtype estimated hazard ratios (HR) with 95% confidence intervals (CI). Strain analyses were prespecified in patients with preserved LVEF. Results: Among 184 patients (92 TTR, 92 AL; mean age 82±9 vs 67±10 years; 85% vs 53% male), TTR patients had greater wall thickness, ventricular volumes, and late gadolinium enhancement burden. Over 24 months, mortality was higher in AL than TTR (33.7% vs 14.1%, p=0.002, Figure 1). Each 1% increase in LVEF was associated with lower mortality (HR 0.98, 95% CI 0.96-1.00, p=0.034). Among 116 patients with preserved LVEF, each 1% increase in absolute LV longitudinal strain was associated with 23% lower mortality (HR 0.77, 95% CI 0.61-0.97, p=0.029), and each 1% increase in absolute RV longitudinal strain with 11% lower mortality (HR 0.89, 95% CI 0.80-0.99, p=0.035), independent of age, sex, and subtype (Figure 2). Conclusion: In cardiac amyloidosis, CMR-derived LV and RV longitudinal strain were independently associated with all-cause mortality among patients with preserved LVEF, supporting strain as an early marker of adverse prognosis.